Achieve life sciences announces changes in executive leadership and board of directors

Richard stewart reassumes role of chief executive officer thomas king appointed executive chairman of the board of directors seattle and vancouver, british columbia, aug. 26, 2024 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage pharmaceutical company dedicated to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that mr. richard (rick) stewart, achieve's co-founder and current executive chairman, will reassume the role of chief executive officer.
ACHV Ratings Summary
ACHV Quant Ranking